Measure the activity of the sympathetic, the parasympathetic nervous system with every heartbeat and the balance trajectory between them. Use the ANSiscope to monitor Chronic pain
Home
The Company
Products
Technology
Applications
Faq
Newsletters
Posters & Presentations
Publications
Press Coverage
Info for Doctors
Info for Reimbursement
Info for Patients
Info for Researchers
Info for Distribution Partners
Info for OEMs
Info for Investors
Links
Contact Us
ANS Forum










 
 
 

 Fetal Heart Monitoring
 
According to “Fetal Heart Monitoring – Principles & Practices” published by the Association of Women’s Health, Obstetric and Neonatal Nurses(AWHONN), the two most important characteristics of the Fetal Heart Rate (FHR) are variability and accelerations.

In other words, variability of the FHR is nothing other than the response of the fetal Autonomic Nervous System (FANS) and acceleration is nothing other than the variability of the FANS.

Our ANS Monitoring technology applied to the FHR will immediately yield a beat to beat display of the fetal sympathetic, parasympathetic systems and also the fetal sympathovagal balance.

Doing this to the Fetal Heart Monitor is akin to adding computer generated interpretation to the EKG printout. No longer will the doctors have to deduce the variability and the accelerations from the FHM printout. They can immediately look at it on the display at every Fetal Heart Beat.

This is an excellent application of ANS Monitoring and we are keen to develop this application with some urgency.

We would request Doctors who are interested in working with us to contact us at clinical@dyansys.com
 
News and Events
American Diabetes Association Recommends screening for Autonomic Neuropathy
 
Screening for autonomic neuropathy should be instituted at diagnosis of type 2 diabetes and 5 years after the diagnosis of type 1 diabetes
 
American Diabetes Association (ADA), Standard of Medical care in Diabetes, 2006
 
Dyansys introduces Portable ECScope for general physicians/ primary care providers
 
Dyansys gains ISO 13485:2003 certification for Portable ANSiscope, Portable ECScope
 

Dyansys is pleased to announces that European office has granted patent on ANSiscope technology for Germany, France & UK countries. Patent Number - 163947

 
Portable ANSiscope approved for FDA Certification
 
Portable ECScope approved for FDA Certification
Dyansys Product Family
The Portable ANSiscope and ECScope Series for family physicians and field applications 
The P-STIM neurostimulation device for treatment of chronic pain
  more  
Dyansys Application
Chronic & Acute Pain
Anesthesiology
Cardiology
Diabetes
Fetal Heart Monitoring
Measurement of autonomic dysfunction
  more  
Copyright © 2009 DyAnsys Inc. All Rights Reserved
Site designed by Uditi Technologies